Surgery for IDH1/2 wild-type glioma invading the corpus callosum

被引：0
|
作者：
Pamela Franco
Daniel Delev
Debora Cipriani
Nicolas Neidert
Elias Kellner
Waseem Masalha
Bianca Mercas
Irina Mader
Peter Reinacher
Astrid Weyerbrock
Christian Fung
Jürgen Beck
Dieter Henrik Heiland
Oliver Schnell
机构：
[1] Medical Center - University of Freiburg,Department of Neurosurgery
[2] University of Freiburg,Faculty of Medicine
[3] University of Aachen,Department of Neurosurgery
[4] Medical Centre - University of Freiburg,Department of Radiology
[5] Schoen Clinic,Specialist Centre for Radiology
[6] Medical Center- University of Freiburg,Department of Neurosurgery, Division Stereotactic and Functional Neurosurgery
来源：
Acta Neurochirurgica | 2021年 / 163卷
关键词：
Corpus callosum glioblastoma; Butterfly glioblastoma; Glioblastoma; Neurosurgery; IDH status; Molecular diagnosis; Extent of resection;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：937 / 945
页数：8
相关论文
共 50 条
  • [21] Wild-type IDH1 inhibition enhances chemotherapy response in pancreatic cancer
    Zarei, Mehrdad
    Hajihassani, Omid
    Hue, Jonathan J.
    Graor, Hallie J.
    Loftus, Alexander W.
    Rothermel, Luke D.
    Winter, Jordan M.
    CANCER RESEARCH, 2024, 84 (02)
  • [22] Nuclear FABP7 regulates cell proliferation of wild-type IDH1 glioma through caveolae formation
    Kagawa, Yoshiteru
    Umaru, Banlanjo Abdulaziz
    Kanamori, Masayuki
    Zama, Ryo
    Shil, Subrata Kumar
    Miyazaki, Hirofumi
    Kobayashi, Shuhei
    Wannakul, Tunyanat
    Yang, Shuhan
    Tominaga, Teiji
    Owada, Yuji
    MOLECULAR ONCOLOGY, 2022, 16 (01) : 289 - 306
  • [23] CHARACTERIZATION OF DIFFERENTIAL 5-HYDROXYMETHYLCYTOSINE IN IDH1 MUTANT VERSUS IDH1 WILD-TYPE HIGH-GRADE GLIOMAS
    Glowacka, Wioletta
    Jain, Harshika
    Okura, Makiko
    Maimaitiming, Abulizi
    Yasin, Mamatjan
    Farooq, Hamza
    Aldape, Kenneth
    Kongkham, Paul
    NEURO-ONCOLOGY, 2017, 19 : 95 - 95
  • [24] Genomic Profiling Reveals Distinctive Molecular Relapse Patterns in IDH1/2 Wild-Type Glioblastoma
    Riehmer, Vera
    Gietzelt, Jens
    Beyer, Ulrike
    Hentschel, Bettina
    Westphal, Manfred
    Schackert, Gabriele
    Sabel, Michael C.
    Radlwimmer, Bernhard
    Pietsch, Torsten
    Reifenberger, Guido
    Weller, Michael
    Weber, Ruthild G.
    Loeffler, Markus
    GENES CHROMOSOMES & CANCER, 2014, 53 (07): : 589 - 605
  • [25] Contrast enhancement is a prognostic factor in IDH1/2 mutant, but not in wild-type WHO grade II/III glioma as confirmed by machine learning
    Suchorska, Bogdana
    Schueller, Ulrich
    Biczok, Annamaria
    Lenski, Markus
    Albert, Nathalie L.
    Giese, Armin
    Kreth, Friedrich-Wilhelm
    Ertl-Wagner, Birgit
    Tonn, Joerg-Christian
    Ingrisch, Michael
    EUROPEAN JOURNAL OF CANCER, 2019, 107 : 15 - 27
  • [26] Why not wild-type IDH1? Finding novel chemical matter for the forgotten isotype
    Jakob, Clarissa G.
    ACTA CRYSTALLOGRAPHICA A-FOUNDATION AND ADVANCES, 2019, 75 : A58 - A58
  • [27] Metabolism of glioma and IDH1/IDH2 mutations
    Rossetto, M.
    Ciccarino, P.
    Boisselier, B.
    Labussiere, M.
    Sanson, M.
    REVUE NEUROLOGIQUE, 2011, 167 (10) : 699 - 703
  • [28] Evaluation of DNA Methylation Array for Glioma Tumor Profiling and Description of a Novel Epi-Signature to Distinguish IDH1/IDH2 Mutant and Wild-Type Tumors
    Schenkel, Laila C.
    Mathew, Joseph
    Hirte, Hal
    Provias, John
    Pare, Guillaume
    Chong, Michael
    Grafodatskaya, Daria
    McCready, Elizabeth
    GENES, 2022, 13 (11)
  • [29] MOLECULAR PROFILING IDENTIFIES INCREASED TRANSGELIN-2 EXPRESSION IN LOW(ER) GRADE GLIOMAS WITH WILD-TYPE IDH1/2 VS. MUTANT IDH1/2
    Beyer, Sasha
    Bell, Erica H.
    McElroy, Joseph P.
    Oehkke, Oliver
    Fleming, Jessica
    Becker, Aline Paixao
    Cui, Tiantian
    Staszewski, Ori
    Prinz, Marco
    Grosu, Anca-Ligia
    Haque, S. Jaharul
    Chakravarti, Arnab
    NEURO-ONCOLOGY, 2017, 19 : 50 - 50
  • [30] Wild-type and mutated IDH1/2 enzymes and therapy responses (vol 37, pg 1949, 2018)
    Molenaar, Remco J.
    Maciejewski, Jaroslaw P.
    Wilmink, Johanna W.
    van Noorden, Cornelis J. F.
    ONCOGENE, 2018, 37 (43) : 5810 - 5810
12345